Late Phase Market Dynamics

Consistent with ISR’s mission, this study tackles significant industry issues with rigor and insight. It is a landmark study based on interviews with 149 decision-makers from around the world representing 95 unique pharma and biotech companies. Respondents discuss in detail their plans for study conduct and outsourcing across various Late Phase study categories.In addition, respondents provide their perceptions of – and experiences with – dozens of Late Phase service providers. The report contains 153 pages, including novel and insightful analyses and nearly 200 charts and graphs.

Readers will gain an in-depth understanding of:

• Late Phase market size and growth
• Late Phase service provider service quality and customer loyalty
• What drives sponsors’ selection of Late Phase service providers
• What drives sponsors’ satisfaction with Late Phase service delivery
• The complex decision-making units within sponsor companies
  and much more...